Home Nucleus Healthcare IT New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032

New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032

Overview

The New Zealand Artificial Intelligence (AI) in Drug Discovery Market is expected to reach a 34.09 USD Million by 2032 and is projected to grow at a CAGR of 73.66% from 2025 to 2032.

Revenue, 2024 (USD Million)
1.68
Forecast, 2032 (USD Million)
34.09
CAGR, 2024 - 2032
73.66%
Report Coverage
New Zealand

New Zealand Artificial Intelligence (AI) in Drug Discovery Market 2018-2032 USD Million

New Zealand Artificial Intelligence (AI) in Drug Discovery Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 1.68 USD Million
  • Projected Market Size (2032): 34.09 USD Million
  • CAGR (2025-2032): 73.66%

Key Findings of New Zealand Artificial Intelligence (AI) in Drug Discovery Market

  • The New Zealand Artificial Intelligence (AI) in Drug Discovery Market was valued at 1.68 USD Million in 2024.
  • The New Zealand Artificial Intelligence (AI) in Drug Discovery Market is likely to grow at a CAGR of 73.66% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Small Molecule in Drug Type Segment accounted for the largest share of the market with a revenue of 1.38 USD Million
  • The fastest growing segment Novel Drug Candidates in Application Segment grew Fastest with a CAGR of 86.74% during the forecast period from 2024 to 2032.

New Zealand Artificial Intelligence (AI) in Drug Discovery Market Scope

New Zealand Artificial Intelligence (AI) in Drug Discovery Market Segmentation & Scope
Application
  • Others
  • Finding New Disease-Associated Targets and Pathways
  • Understanding Disease Mechanisms
  • Formation & Qualification of Hypotheses
  • Finding Drug Targets of an Old Drug
  • De Novo Drug Design
  • Aggregating and Synthesizing Information
  • Drug Monitoring
  • Drug Optimisation and Re-purposing Pre-clinical testing and approval
  • Novel Drug Candidates
Indication
  • Others
  • Metabolic Diseases
  • Cardiovascular Diseases
  • Neurodegenerative Diseases
  • Immuno-Oncology
Offering
  • Services
  • Software
Technology
  • Others
  • Natural Language Processing (NLP)
  • Deep Learning
  • Machine Learning (ML)
Drug Type
  • Large Molecule
  • Small Molecule
End User
  • Others
  • Research Centres and Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations

New Zealand Artificial Intelligence (AI) in Drug Discovery Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Million
Market Value in 2024 1.68 USD Million
Market Value in 2032 34.09 USD Million
CAGR (2025-2032) 73.66%
Historic Data 2016-2023
Market Segments Covered Application,Indication,Offering,Technology,Drug Type,End User

Regional Insights:

  • Leading Market (2024-2032): New Zealand, leading in terms of revenue 1.68 USD Million in 2024
    • Key Country: New Zealand, leading in terms of revenue with value of 1.68 USD Million in 2024.

Segments and Scope

  • New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Application
    • Novel Drug Candidates is the largest segment in New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 0.55 USD Million in the year 2024.
    • Novel Drug Candidates is the Fastest growing segment in New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 86.74 % in forecast period 2025-2032.
  • New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Indication
    • Immuno-Oncology is the largest segment in New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 0.72 USD Million in the year 2024.
    • Immuno-Oncology is the Fastest growing segment in New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 76.45 % in forecast period 2025-2032.
  • New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Offering
    • Software is the largest segment in New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 0.99 USD Million in the year 2024.
    • Services is the Fastest growing segment in New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 69.85 % in forecast period 2025-2032.
  • New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Technology
    • Machine Learning (ML) is the largest segment in New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 0.88 USD Million in the year 2024.
    • Machine Learning (ML) is the Fastest growing segment in New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 75.78 % in forecast period 2025-2032.
  • New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Drug Type
    • Small Molecule is the largest segment in New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 1.38 USD Million in the year 2024.
    • Small Molecule is the Fastest growing segment in New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 74.25 % in forecast period 2025-2032.
  • New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032, By End User
    • Contract Research Organizations is the largest segment in New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 0.82 USD Million in the year 2024.
    • Contract Research Organizations is the Fastest growing segment in New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 78.01 % in forecast period 2025-2032.

New Zealand Artificial Intelligence (AI) in Drug Discovery Market Company Share Analysis

 
Company Name Company Share Analysis
Microsoft
NVIDIA Corporation
IBM Corporation
Schrödinger, Inc.
BPGbio, Inc.
New Zealand Artificial Intelligence (AI) in Drug Discovery Market Company Share Analysis

New Zealand Artificial Intelligence (AI) in Drug Discovery Market Geographical Sales Distribution, 2018-2032 USD Million

New Zealand Artificial Intelligence (AI) in Drug Discovery Market Geographical Sales Distribution, 2018-2032 USD Million

New Zealand Artificial Intelligence (AI) in Drug Discovery Market Company Profiling

New Zealand Artificial Intelligence (AI) in Drug Discovery Market Company Profiling

Industry Related Reports

South America Digital Therapeutic (DTx) Market
Middle East & Africa Digital Therapeutic (DTx) Market
North America Digital Therapeutic (DTx) Market
Europe Digital Therapeutic (DTx) Market
Asia-Pacific Digital Therapeutic (DTx) Market
Argentina Digital Therapeutic (DTx) Market
Australia Digital Therapeutic (DTx) Market
Belgium Digital Therapeutic (DTx) Market
Brazil Digital Therapeutic (DTx) Market
Canada Digital Therapeutic (DTx) Market
Frequently Asked Questions
The New Zealand Artificial Intelligence (AI) in Drug Discovery Market is segmented based on Segmentation Application,Indication,Offering,Technology,Drug Type,End User.
New Zealand Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 1.68(Revenue in USD Million) in 2020.
New Zealand Artificial Intelligence (AI) in Drug Discovery Market is projected to grow at a CAGR of 73.66% during the forecast period of 2024 to 2032.
The Small Molecule segment is expected to dominate the New Zealand Artificial Intelligence (AI) in Drug Discovery Market, holding a largest market share of 1.38 USD Million in 2024

Coming Soon....

New Zealand Artificial Intelligence (AI) in Drug Discovery Market Scope

New Zealand Artificial Intelligence (AI) in Drug Discovery Market Segmentation & Scope
Application
  • Others
  • Finding New Disease-Associated Targets and Pathways
  • Understanding Disease Mechanisms
  • Formation & Qualification of Hypotheses
  • Finding Drug Targets of an Old Drug
  • De Novo Drug Design
  • Aggregating and Synthesizing Information
  • Drug Monitoring
  • Drug Optimisation and Re-purposing Pre-clinical testing and approval
  • Novel Drug Candidates
Indication
  • Others
  • Metabolic Diseases
  • Cardiovascular Diseases
  • Neurodegenerative Diseases
  • Immuno-Oncology
Offering
  • Services
  • Software
Technology
  • Others
  • Natural Language Processing (NLP)
  • Deep Learning
  • Machine Learning (ML)
Drug Type
  • Large Molecule
  • Small Molecule
End User
  • Others
  • Research Centres and Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
Frequently Asked Questions
The New Zealand Artificial Intelligence (AI) in Drug Discovery Market is segmented based on Segmentation Application,Indication,Offering,Technology,Drug Type,End User.
New Zealand Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 1.68(Revenue in USD Million) in 2020.
New Zealand Artificial Intelligence (AI) in Drug Discovery Market is projected to grow at a CAGR of 73.66% during the forecast period of 2024 to 2032.
The estimated market value of the New Zealand Artificial Intelligence (AI) in Drug Discovery Market for final year is USD 34.09 (USD Million).

New Zealand Artificial Intelligence (AI) in Drug Discovery Market Company Profiling

New Zealand Artificial Intelligence (AI) in Drug Discovery Market Company Profiling
Frequently Asked Questions
The New Zealand Artificial Intelligence (AI) in Drug Discovery Market is segmented based on Segmentation Application,Indication,Offering,Technology,Drug Type,End User.
New Zealand Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 1.68(Revenue in USD Million) in 2020.
New Zealand Artificial Intelligence (AI) in Drug Discovery Market is projected to grow at a CAGR of 73.66% during the forecast period of 2024 to 2032.
The estimated market value of the New Zealand Artificial Intelligence (AI) in Drug Discovery Market for final year is USD 34.09 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.